Allspring Global Investments Holdings LLC decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 18.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,889 shares of the biopharmaceutical company’s stock after selling 6,492 shares during the period. Allspring Global Investments Holdings […]
Royal Bank of Canada reissued their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $270.00 price target on the biopharmaceutical company’s stock. ALNY has been the topic of a number of other reports. Sanford C. Bernstein decreased their […]
StockNews com Initiates Coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eighteen brokerages that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average […]
Endurant Capital Management LP purchased a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 4,596 shares of the biopharmaceutical company’s stock, valued at approximately $1,092,000. A number of […]